The Legal 500 > Gardner Leader LLP > Newbury, ENGLAND > Lawyer profiles

Gardner Leader LLP

WHITE HART HOUSE, MARKET PLACE, NEWBURY, RG14 5BA, ENGLAND

Tel:: Work 01635 508080
Fax:: Fax 01635 521341
DX:: 30805 NEWBURY

Email:

Web:: www.gardner-leader.co.uk

Maidenhead, Newbury, Thatcham

Andrew Shipp

Tel:: Work 01635 508138
Email:

Web:: www.gardner-leader.co.uk/specialist/andrew-shipp/

Profile
Lawyer Rankings

Work Department

Commercial litigation and Property litigation

Position

Andrew is a Senior Associate at Gardner Leader in the Dispute Resolution Team.

The main focus of Andrew’s work is commercial disputes. He deals with a range of issues including contractual disputes, debt recovery and shareholder/director disputes.

Andrew also deals with intellectual property disputes including copyright and trademark infringement.

Andrew has a great deal of experience with insolvency matters and acts for Insolvency Practitioners pursuing book debts, contractual claims and delinquent directors.

The other focus of Andrew’s caseload is property litigation. He has acted for a number of clients on a broad range of issues such as boundary disputes, rights of way, construction disputes including adjudication, and landlord and tenant matters, including possession claims, dilapidations and lease disputes.

South East: Dispute resolution

Commercial litigation: Thames Valley, Berks, Oxon, M4/M40

Within: Commercial litigation: Thames Valley, Berks, Oxon, M4/M40

Gardner Leader LLP's practice ‘punches well above its weight, providing a very attractive client proposition: City-quality advice at provincial charging rates’. Chris Felton ‘is as able as any City litigator; he has invaluable litigation instincts coupled with great knowledge and experience, especially in international litigation and arbitration’. Felton successfully had claims of around £160,000, which were brought against two clients in their roles as partners in HLM Properties, struck out as an abuse of process. Michelle Di Gioia acted for litigation funder Managed Legal Solutions in respect of a security for costs application valued at £6.8m as part of the Seroxat group litigation, with an outcome which is set to have wide-ranging implications for litigation funders. Clients also include Swynson Limited. Senior associates Hilary Messer and Violetta Falla and associate Andrew Shipp are also noted members of the team. Solicitor Katie Dyson joined the team in January 2018 from Simmons & Simmons, adding her expertise in complex commercial disputes and financial litigation.

[back to top]

South East: Insurance

Personal injury: claimant

Within: Personal injury: claimant

Gardner Leader LLP's personal injury team has niche expertise in transport accidents and disasters, road traffic collisions and various aviation accidents. The practice also handles claims involving physical and psychological workplace injuries. Associate Andrew Shipp acted for a claimant who damaged their wrist and shoulder after falling over a box at work, leading to surgery and other treatments, as well as representing a man who was hit by a car, suffered internal bleeding and had to be brought back to life twice on his way to the hospital. Partner Alastair Goggins serves as head of dispute resolution.

[back to top]

Back to index

Search News and Articles

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

OLG München on post-contractual non-compete clauses for managing directors

Post-contractual non-compete clauses for managing directors are standard practice. But should these clauses go beyond the scope of what is necessary, they may be deemed to be null and void in their entirety.

- GRP Rainer LLP
Licensed Insolvency Practitioners

Two of our Senior Associates, Mrs Nasia Papakonstantinou and Mr Christos Ioannou, successfully passed their Insolvency Practitioners examinations and are now officially included in the Cyprus Insolvency Service (ISC).

- Patrikios Pavlou & Associates LLC
Use of a Feed-In Premium for Photovoltaic Electricity

The Government of North Macedonia announced an open call for awarding a contract for the use of a feed-in premium for electricity produced in photovoltaic power plants (“PVPPs ”) on state land in North Macedonia, with total installed capacity of 35 MW. Two locations are envisaged for construction of the PVPPs – Azambegovo (Sveti Nikole) and Manastirec (Makedonski Brod). Bidders can submit a bid for three PVPPs, at most, for the location of Azambegovo, as well as one PVPP on the location of Manastirec. The installed capacity of the PPVPs on the mentioned locations can be 10 MW, 5 MW, 2 MW and 1 MW depending on the parcel. The term of the contract for the use of a feed-in premium will be 15 years.

- Karanovic & Nikolic

Welcome to the Slovenian Legal Market

This article is written by Marko Ketler and originally published in Issue 6.4 of the CEE Legal Matters Magazine .

- Karanovic & Nikolic

Investing in the Slovenian Automotive Production Industry

This article was written by Igor Angelovski and was originally published in Issue 6.2 of the CEE Legal Matters Magazine.

- Karanovic & Nikolic

Unreported income in foreign accounts – Immunity still possible through voluntary disclosure

Voluntary disclosure leading to immunity from tax evasion charges is still a current topic. It remains the only way of returning to a state of tax compliance.

- GRP Rainer LLP

Hengeler Mueller advises Axel Springer SE on strategic partnership with KKR

Axel Springer SE has signed an investor agreement with a holding company owned by funds advised by investment firm Kohlberg Kravis Roberts (KKR) and investment entities controlled by Friede Springer and CEO Mathias Döpfner to create a strategic partnership.

- Hengeler Mueller

Bär & Karrer Advises Swedish Orphan Biovitrum AB in the Acquisition of emapalumab

Swedish Orphan Biovitrum AB, an international specialty biopharmaceutical company listed in Sweden, agreed to acquire, from Novimmune’s shareholders, a newly established company owning emapalumab and related assets, giving Sobi access to world-class R&D capabilities in the field of Immunology. The acquisition supersedes the previously announced exclusive licence agreement with Novimmune. In addition, Sobi agreed with Novimmune on options for the shared financial rights to NI-1701 and NI-1801, two product candidates in the field of immuno-oncology. The transaction value is CHF 515 million, of which CHF 400 million was previously committed in the exclusive license agreement for emapalumab.

- BÄR & KARRER LTD.

European and Italian rules on Fluorinated gases

1. Overview

- Villata, Degli Esposti e Associati

Bär & Karrer Advises Patinex and BZ Bank on the Sale of NovImmune to Light Chain Bioscicence

Light Chain Bioscience AG, a Swiss biotech company, agreed to purchase all shares in NovImmune SA, a company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune related disorders and cancer. Patinex and BZ Bank are the selling majority shareholders of NovImmune.

- BÄR & KARRER LTD.

Lawyer rankings